Provided by Tiger Trade Technology Pte. Ltd.

California Resources

52.43
+0.77001.49%
Post-market: 52.430.00000.00%19:30 EDT
Volume:726.45K
Turnover:38.00M
Market Cap:4.65B
PE:-37.35
High:52.67
Open:51.24
Low:51.24
Close:51.66
52wk High:71.98
52wk Low:43.25
Shares:88.60M
Float Shares:84.41M
Volume Ratio:0.87
T/O Rate:0.86%
Dividend:1.60
Dividend Rate:3.06%
EPS(TTM):-1.4038
EPS(LYR):4.15
ROE:-3.55%
ROA:0.24%
PB:1.37
PE(LYR):12.63

Loading ...

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Reuters
·
Sep 10

California Resources Corp (CRC) Has a New Rating from Stifel Nicolaus

TIPRANKS
·
Sep 10

California Resources resumed with a Buy at Stifel

TIPRANKS
·
Sep 10

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

GlobeNewswire
·
Sep 09

California Resources EVP, Chief Commercial Officer Jay A. Bys Disposes of 11,907 Shares Worth $643,000

Reuters
·
Sep 09

California Resources Corp (CRC) Receives a Hold from Seaport Global

TIPRANKS
·
Sep 03

California Resources Initiated at Neutral by Seaport Global

Dow Jones
·
Sep 03

California Resources initiated with a Neutral at Seaport Research

TIPRANKS
·
Sep 03

California Resources Outlines Potential CO2 Pipeline Network to Link California Emitters with TerraVault Storage Sites

Reuters
·
Sep 02

California Resources Sees 3Q Crimson G&A, Capex at $1-$2 Million Each

Reuters
·
Sep 02

California Resources Corporation Completes Acquisition of Crimson

THOMSON REUTERS
·
Sep 02

Elevance update guidelines cover Freenome CRC test, says Guggenheim

TIPRANKS
·
Sep 01

California Resources Releases 2025 Sustainability Report Update

Reuters
·
Aug 31

Oil Stocks Retail Investors Are Watching For Direct Crude Price Exposure

Simply Wall St.
·
Aug 31

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

GlobeNewswire
·
Aug 25

Is California Resources (CRC) Cheap On Strong Q2 Results And New Production Guidance?

Simply Wall St.
·
Aug 23

Adagene to Participate in Three Upcoming Investor Conferences

GlobeNewswire
·
Aug 20

Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
Aug 13

California Resources EVP, Chief Commercial Officer Jay A. Bys Sells 11,907 Shares for $642,978

Reuters
·
Aug 13

Centuri Names Kelly Youngblood CFO, Replacing Gregory Izenstark

Reuters
·
Aug 13